Table 1.

Clinically relevant Talaromyces species.

Species	Country	Underlying Conditions	Treatment	Outcome
T. amestolkiae	New Caledonia [4] Taiwan	AML case AIDS patients Cystic fibrosis case ALL case	Not mentioned in article	Not mentioned in article
T. marneffei	East Asian countries including China, Taiwan, Thailand, and Vietnam	AIDS	Amphotericin B then Itraconazole	Mortality rate: ~75% in untreated patient ~25% in received treatment patient
T. indigoticus	Nepal, Japan, Thailand, and Western Panama [12]	Diabetes mellitus	Not mentioned in article	Not mentioned in article
T. piceus	Argentina [13]	X-linked chronic granulomatous disease (X-CGD) patient	Amphotericin B then voriconazole due to renal impairment Surgical resection of affected ribs	Recovered and free from fungal infections
	Germany [14]	Alcohol-abused and cholangiocarcinoma		Deceased before treatment
T. stollii	France, Hamburg, and Netherlands [4]	lung transplantation, France AIDS patient; the Netherlands	Not mentioned in article	Not mentioned in article